Check out the companies making headlines before the bell: Oracle — The software giant fell more than 12% after reporting fiscal second-quarter earnings that fell short of analysts’ expectations. Analysts across Wall Street scrambled to lower their price targets. Adobe — Shares fell slightly after the software company announced lackluster fiscal year 2026 outlook. Adobe expects earnings per share to be in the range of $23.30 to $23.50. Analysts polled by FactSet expected earnings of $23.38 per share. Eli Lilly — A late-stage trial showed that the company’s next-generation obesity drug, letaltortide, reduced knee arthritis pain while producing what appeared to be the highest weight loss effect ever. The stock rose 2%. Oxford Industries — parent company of Tommy Bahama and Lilly Pulitzer — fell 21.9% after the apparel maker gave a weak outlook for the current quarter and cut its full-year profit outlook. Oxford expects earnings per share of $2.20 to $2.40 this year, excluding items, while analysts surveyed by FactSet expected earnings of $2.90 per share. Gemini Space Station — Stocks rose 15% after cryptocurrency exchange secured license to offer prediction markets to U.S. customers Visa — Payments stocks rose 1% after Trust Inc. listed Visa as one of its favorite stocks for 2026, calling the company a “favorable quality compounder.” Corbus Pharmaceuticals — The biopharmaceutical company rose more than 7% after reporting results from a Phase 1a trial that showed its obesity drug had a favorable safety profile and new evidence of weight loss. Planet Labs — The satellite imaging company soared more than 17% after Planet Labs posted third-quarter sales of $81 million. This beat LSEG’s consensus estimate of $72 million. — CNBC’s Michelle Fox, Alex Harring, Fred Imbert and Liz Napolitano contributed reporting
